Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.750
-0.710-3.85%
Volume:5.21M
Turnover:91.95M
Market Cap:18.23B
PE:-20.40
High:18.300
Open:18.300
Low:17.350
Close:18.460
52wk High:38.640
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:1.33
T/O Rate:2.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.63
PE(LYR):-20.40
PS:5.16

Loading ...

Junshi Bio (01877) Announces Updated Board Composition and Committee Structure

Bulletin Express
·
Mar 13

Junshi Bio (01877) Elevates Strategic Focus with New ESG Mandate and Drafts Director & Executive Pay Policies

Bulletin Express
·
Mar 13

BRIEF-Shanghai Junshi Biosciences Says Resolution On Temporary Replenishment Of Liquidity Approved

Reuters
·
Mar 13

Junshi Bio (01877) Fully Returns RMB1.11 Billion of Idle Proceeds Previously Deployed for Working-Capital Needs

Bulletin Express
·
Mar 12

Shanghai Junshi Biosciences - Proceeds Would Only Be Used for Business Expansion, Others

THOMSON REUTERS
·
Mar 12

Shanghai Junshi Biosciences - Resolution on Temporary Replenishment of Liquidity Approved to Use Idle Proceeds of No More Than RMB2 Bln (Inclusive)

THOMSON REUTERS
·
Mar 12

Junshi Biosciences Excluded from STAR 50 Index as Revenue Growth Fails to Reverse Loss Trend

Deep News
·
Mar 12

BRIEF-Shanghai Junshi Biosciences Says Chairman Intended To Increase Shareholding In Co

Reuters
·
Mar 11

JUNSHI BIO Chairman Xiong Jun Increases Holdings with 100,000 A Shares

Stock News
·
Mar 10

Shanghai Junshi Biosciences - Chairman Intended to Increase Shareholding in Both a Shares & H Shares of Co for Not Less Than RMB100 Mln

THOMSON REUTERS
·
Mar 10

Junshi Biosciences' Toripalimab Injection Accepted for Review in China; Hong Kong Shares Up 6%

MT Newswires Live
·
Mar 10

JUNSHI BIO Shares Surge Over 7% Following New Drug Application Acceptance

Stock News
·
Mar 10

Shanghai Junshi Biosciences - Acceptance of New Drug Applications for Toripalimab- Injection by Nmpa

THOMSON REUTERS
·
Mar 09

JUNSHI BIO (01877) Releases February 2026 Monthly Return on Securities Movements

Bulletin Express
·
Mar 04